NEUROBRIDGE LIMITED

Company Registration Number:
14895457 (England and Wales)

Unaudited micro entity accounts for the year ended 31 May 2025

Period of accounts

Start date: 01 June 2024

End date: 31 May 2025

NEUROBRIDGE LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2025

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

NEUROBRIDGE LIMITED

Company Information

for the Period Ended 31 May 2025




Registered office: Suite 46
24-28 St. Leonards Road
Windsor
England
SL4 3BB
Company Registration Number: 14895457 (England and Wales)

NEUROBRIDGE LIMITED

Profit and Loss Account

for the Period Ended 31 May 2025


2025
£

2024
£
Turnover 105,541 13,490
Cost of Materials ( 1,644 ) ( 0 )
Staff Costs ( 159,391 ) ( 15,727 )
Depreciation and Writeoffs ( 1,581 ) ( 870 )
Other charges ( 167,674 ) ( 29,010 )
Profit or (Loss) for Period ( 224,749 ) ( 32,117 )

NEUROBRIDGE LIMITED

Balance sheet

As at 31 May 2025


2025
£

2024
£
Called up share capital not paid: 0 0
Fixed Assets: 5,453 3,481
Current assets: 258,592 18,866
Prepayments and accrued income: 12,094
Creditors: amounts falling due within one year: ( 44,422 ) ( 6,840 )
Net current assets (liabilities): 226,264 12,026
Total assets less current liabilities: 231,717 15,507
Creditors: amounts falling due after more than one year: ( 26,624 ) ( 32,622 )
Accruals and deferred income: ( 61,713 ) ( 15,000 )
Total net assets (liabilities): 143,380 ( 32,115 )
Capital and reserves: 143,380 ( 32,115 )

NEUROBRIDGE LIMITED

Balance sheet continued

For the year ending 31 May 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 2 January 2026
And Signed On Behalf Of The Board By:

Name: Joshua Goodison
Status: Director

The notes form part of these financial statements

NEUROBRIDGE LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 May 2025

  • 1. Employee Information

    Average number of employees: 3

NEUROBRIDGE LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 May 2025

  • 2. Off balance sheet disclosure

    No